The Vigilance and Benefit- Risk Assessment Executive Directorate is responsible for all activities related to pre- and post marketing assessment of safety and efficacy of registered products.
The Executive Directorate is divided into three main departments:
- National Pharmacovigilance and Drug Safety Center (NPC).
- Benefit- Risk Assessment Department (BRAD).
- Medication Errors Department.
Important Links
European Medicine Agaency
Australian Government - Department of Health
Medicines and Healthcare products Regulatory Agency
MedWatch
